Jared A. Olson

Jared A. Olson, PharmD, BCPPS, FPIDS

Languages spoken: English

Academic Information

Departments Primary - Pediatrics

Divisions: Infectious Diseases

Board Certification

  • Board of Pharmacy Specialties (Sub: Pediatric Pharmacy)

Education History

Residency Primary Children’s Medical Center
 Resident
Midwestern University
 PharmD
Undergraduate Brigham Young University
 BA

Selected Publications

Journal Article

  1. Ingalls EM, Veillette JJ, Olson J, May SS, Dustin Waters C, Gelman SS, Vargyas G, Hutton M, Tinker N, Fontaine GV, Foster RA, Stallsmith J, Earl A, Buckel WR, Vento TJ (2023). Impact of a Multifaceted Intervention on Antibiotic Prescribing for Cystitis and Asymptomatic Bacteriuria in 23 Community Hospital Emergency Departments. Hosp Pharm, 58(4), 401-407. (Read full article)
  2. Veillette JJ, Waters CD, Olson J, Vargyas G, Ingalls EM, Hutton MA, Tinker N, May SS, Foster RA, Stallsmith J, Vento TJ (2023). Outcomes of patients with bacteriuria/pyuria of clinically undetermined significance (BPCUS) treated with antibiotics in 23 community hospital emergency departments. Antimicrob Steward Healthc Epidemiol, 3(1), e114. (Read full article)
  3. Gray L, Olson J, Brintz BJ, Cipriano SD (2022). Staphylococcal scalded skin syndrome: Clinical features, ancillary testing, and patient management. Pediatr Dermatol, 39(6), 908-913. (Read full article)
  4. Olson J, Franz-ONeal E, Cipriano FA, Ou Z, Presson AP, Thorell EA (2022). Impact of Early Oral Antibiotic Therapy in Infants With Bacteremic Urinary Tract Infections. Hosp Pediatr, 12(7), 632-638. (Read full article)
  5. OLeary EN, Edwards JR, Srinivasan A, Neuhauser MM, Soe MM, Webb AK, Edwards EM, Horbar JD, Soll RF, Roberts J, Hicks LA, Wu H, Zayack D, Braun D, Cali S, Edwards WH, Flannery DD, Fleming-Dutra KE, Guzman-Cottrill JA, Kuzniewicz M, Lee GM, Newland J, Olson J, Puopolo KM, Rogers SP, Schulman J, Septimus E, Pollock DA (2022). National Healthcare Safety Network 2018 Baseline Neonatal Standardized Antimicrobial Administration Ratios. Hosp Pediatr, 12(2), 190-198. (Read full article)
  6. Franz-ONeal E, Olson J, Thorell EA, Cipriano FA (2021). Follow-Up Blood Cultures in Young Infants With Bacteremic Urinary Tract Infections. Hosp Pediatr. (Read full article)
  7. Jones TW, Fino N, Olson J, Hersh AL (2020). The impact of beta-lactam allergy labels on hospitalized children. Infect Control Hosp Epidemiol, 42(3), 318-324. (Read full article)
  8. Olson J, Mehra S, Hersh AL, Thorell EA, Stoddard GJ, Maese L, Barnette PE, Lemons RS, Pavia AT, Knackstedt ED (2019). Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer. J Pediatric Infect Dis Soc, 10(1), 27-33. (Read full article)
  9. Veillette JJ, Waters CD, Gelman SS, Hoopes L, Vargyas G, McKay A, Good T, Olson J, Vento TJ (2020). Antibiotic prescribing for adult bacteriuria and pyuria in community hospital emergency departments. Am J Emerg Med, 40, 1-5. (Read full article)
  10. Olson J, Hersh AL, Sorensen J, Zobell J, Anderson C, Thorell EA (2019). Intravenous Vancomycin Therapeutic Drug Monitoring in Children: Evaluation of a Pharmacy-Driven Protocol and Collaborative Practice Agreement. J Pediatric Infect Dis Soc, 9(3), 334-341. (Read full article)
  11. Lane RD, Olson J, Reeder R, Miller B, Workman JK, Thorell EA, Larsen GY (2020). Antibiotic Timing in Pediatric Septic Shock. Hosp Pediatr, 10(4), 311-317. (Read full article)
  12. Olson J, Thorell EA, Hersh AL (2018). Evaluation of Discharge Antibiotic Prescribing at a Freestanding Children's Hospital: Opportunities for Stewardship. J Pediatric Infect Dis Soc, 8(6), 563-566. (Read full article)
  13. Wolsey A, Wilcox RA, Olson JA, Boehme S, Anderson CR (2019). Retrospective comparison of two enoxaparin dosing and monitoring protocols at a pediatric hospital. Am J Health Syst Pharm, 76(11), 815-819. (Read full article)
  14. Anderson CR, Lueckler J, Olson JA (2019). Influencing the timing of parenteral nutrition initiation in the pediatric intensive care unit. Pharm Pract (Granada), 17(2), 1416. (Read full article)
  15. Stockmann C, Olson J, Rashid J, Lubsch L, Young DC, Hersh AL, Frymoyer A, Ampofo K, Liu X, Wang Y, Sherwin CMT, Zobell JT (2018). An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus. J Clin Pharmacol, 59(2), 198-205. (Read full article)
  16. Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, Hersh AL, Tamma PD (2017). Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children. J Pediatric Infect Dis Soc, 7(4), 338-341. (Read full article)
  17. Quinn NA, Olson JA, Meier JD, Baskin H, Schunk JE, Thorell EA, Hodo LN (2018). Pediatric lateral neck infections - Computed tomography vs ultrasound on initial evaluation. Int J Pediatr Otorhinolaryngol, 109, 149-153. (Read full article)
  18. Hersh AL, Olson J, Stockmann C, Thorell EA, Knackstedt ED, Esquibel L, Sanderson S, Pavia AT (2016). Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy. J Pediatric Infect Dis Soc, 7(2), e34-e36. (Read full article)
  19. Krah NM, Olson J, Thorell EA, Esquibel L, Osguthorpe RJ, Pavia AT, Hersh AL (2017). Outpatient Parenteral Antimicrobial Therapy in Young Infants. J Pediatric Infect Dis Soc, 7(2), e40-e42. (Read full article)
  20. Hamdy RF, Hsu AJ, Stockmann C, Olson JA, Bryan M, Hersh AL, Tamma PD, Gerber JS (2017). Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children. Pediatrics, 139(6). (Read full article)
  21. Ames SG, Workman JK, Olson JA, Korgenski EK, Masotti S, Knackstedt ED, Bratton SL, Larsen GY (2015). Infectious Etiologies and Patient Outcomes in Pediatric Septic Shock. J Pediatric Infect Dis Soc, 6(1), 80-86. (Read full article)
  22. Veesenmeyer AF, Olson JA, Hersh AL, Stockmann C, Korgenski K, Thorell EA, Pavia AT, Blaschke AJ (2016). A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures. Infect Dis Ther, 5(4), 555-570. (Read full article)
  23. Grant MJ, Olson J, Gerber A (2015). Clinician response time for positive blood culture results in a pediatric ICU. Heart Lung, 44(5), 426-9. (Read full article)
  24. Yu T, Stockmann C, Healy DP, Olson J, Wead S, Neely AN, Kagan RJ, Spigarelli MG, Sherwin CM (2014). Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis. J Burn Care Res, 36(4), e244-52. (Read full article)
  25. Zobell JT, Epps KL, Young DC, Montague M, Olson J, Ampofo K, Chin MJ, Marshall BC, Dasenbrook E (2015). Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol, 50(6), 552-9. (Read full article)
  26. Evans RS, Olson JA, Stenehjem E, Buckel WR, Thorell EA, Howe S, Wu X, Jones PS, Lloyd JF (2015). Use of computer decision support in an antimicrobial stewardship program (ASP). Appl Clin Inform, 6(1), 120-35. (Read full article)
  27. Anderson CR, Olson JA (2015). Correlation of weight-based i.v. immune globulin doses with changes in serum immunoglobulin G levels. Am J Health Syst Pharm, 72(4), 285-9. (Read full article)
  28. Skarda DE, Schall K, Rollins M, Andrews S, Olson J, Greene T, McFadden M, Thorell EA, Barnhart D, Meyers R, Scaife E (2014). A dynamic postoperative protocol provides efficient care for pediatric patients with non-ruptured appendicitis. J Pediatr Surg, 50(1), 149-52. (Read full article)
  29. Skarda DE, Schall K, Rollins M, Andrews S, Olson J, Greene T, McFadden M, Thorell EA, Barnhart D, Meyers R, Scaife E (2014). Response-based therapy for ruptured appendicitis reduces resource utilization. J Pediatr Surg, 49(12), 1726-9. (Read full article)
  30. Sherwin CM, Zobell JT, Stockmann C, McCrory BE, Wisdom M, Young DC, Olson J, Ampofo K, Spigarelli MG (2014). Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis. J Pharmacokinet Pharmacodyn, 41(1), 71-9. (Read full article)
  31. Stockmann C, Sherwin CM, Zobell JT, Lubsch L, Young DC, Olson J, Noyes BE, Ampofo K, Spigarelli MG (2013). Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis. Pharmacotherapy, 33(12), 1288-96. (Read full article)
  32. Zobell JT, Young DC, Waters CD, Ampofo K, Cash J, Marshall BC, Olson J, Chatfield BA (2011). A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatr Pulmonol, 46(10), 987-90. (Read full article)

Review

  1. Burgunder L, Heyrend C, Olson J, Stidham C, Lane RD, Workman JK, Larsen GY (2022). Medication and Fluid Management of Pediatric Sepsis and Septic Shock. [Review]. Paediatr Drugs, 24(3), 193-205. (Read full article)
  2. Job KM, Olson J, Stockmann C, Constance JE, Enioutina EY, Rower JE, Linakis MW, Balch AH, Yu T, Liu X, Thorell EA, Sherwin CM (2016). Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections. [Review]. Expert Rev Anti Infect Ther, 14(8), 731-46. (Read full article)
  3. Stockmann C, Constance JE, Roberts JK, Olson J, Doby EH, Ampofo K, Stiers J, Spigarelli MG, Sherwin CM (2014). Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications. [Review]. Clin Pharmacokinet, 53(5), 429-54. (Read full article)
  4. Stockmann C, Spigarelli MG, Campbell SC, Constance JE, Courter JD, Thorell EA, Olson J, Sherwin CM (2013). Considerations in the pharmacologic treatment and prevention of neonatal sepsis. [Review]. Paediatr Drugs, 16(1), 67-81. (Read full article)

Other

  1. Alzaidi S, Veillette JJ, May SS, Olson J, Jackson K, Waters CD, Butler AM, Hutton MA, Buckel WR, Webb BJ (2023). Oral β-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia From a Urinary Tract Source. Open Forum Infect Dis (11(2), pp. ofad657). United States. (Read full article)